...
首页> 外文期刊>Biotechnology and Bioengineering >Directed Evolution of the Substrate Specificity of Biotin Ligase
【24h】

Directed Evolution of the Substrate Specificity of Biotin Ligase

机译:生物素连接酶底物特异性的定向进化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We have developed selection scheme for directing the evolution of Escherichia coli biotin protein ligase (BPL) via in vitro compartmentalization, and have used this scheme to alter the substrate specificity of the ligase towards the utilization of the biotin analogue desthiobiotin. In this scheme, a peptide substrate (BAP) was conjugated to a DNA library encoding BirA, emulsified such that there was a single template per compartment, and protein variants were transcribed and translated in vitro. Those variants that could efficiently desthiobiotinylate their corresponding peptide: DNA conjugate were subsequently captured and amplified. Following just six rounds of selection and amplification several variants that demonstrated higher activity with desthiobiotin were identified. The best variants from Round 6, BirA_(6–40) and BirA_(6–47), showed 17-fold and 10-fold higher activity, respectively, their abilities to use desthiobiotin as a substrate. While selected enzymes contained a number of substitutions, a single mutation, M157T, proved sufficient to provide much greater activity with desthiobiotin. Further characterization of BirA_(6–40) and the single substitution variant BirA_(M157T) revealed that they had twoto threefold higher k_(cat) values for desthiobiotin. These variants had also lost much of their ability to utilize biotin, resulting in orthogonal enzymes that in conjunction with streptavidin variants that can utilize desthiobiotin may prove to be of great use in developing additional, robust conjugation handles for a variety of biological and biotechnological applications.
机译:我们已经开发了用于通过体外区室化指导大肠杆菌生物素蛋白连接酶(BPL)进化的选择方案,并已使用该方案来改变连接酶的底物特异性,以利用生物素类似物脱硫生物素。在该方案中,将肽底物(BAP)与编码BirA的DNA文库缀合,进行乳化,使得每个隔室只有一个模板,并在体外转录和翻译蛋白质变体。随后可以捕获并扩增那些可以有效地对它们的相应肽进行脱硫生物素化的变体:DNA缀合物。仅经过六轮选择和扩增,就发现了几个表现出具有脱硫生物素更高活性的变体。第6轮的最佳变种BirA_(6-40)和BirA_(6-47)分别显示出高17倍和10倍的活性,它们具有使用脱硫生物素作为底物的能力。尽管所选的酶包含许多取代,但事实证明,单个突变M157T足以为脱硫生物素提供更大的活性。 BirA_(6–40)和单取代变体BirA_(M157T)的进一步表征表明,它们的去硫生物素k_(cat)值高两倍至三倍。这些变体也失去了许多利用生物素的能力,从而导致正交酶与可以利用去硫生物素的链霉亲和素变体结合在一起,可能被证明在开发用于各种生物和生物技术应用的其他稳固的结合柄中很有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号